The shareholders of Diamyd Medical AB (OM:DIAM B) authorized a share repurchase program at its Annual General Meeting on December 6, 2012. Under the plan, the company will repurchase series B shares. The maximum number of shares repurchased shall be such that Diamyd Medical shares held in treasury from time to time do not exceed 10% of all shares in Diamyd Medical.

Repurchases will be made on NASDAQ OMX Stockholm. Repurchase of shares must be conducted in accordance with the Stock Exchange's Rule Book for Issuers. The purpose of this authorization is to give the Board a tool to optimize the capital structure of the company in order to create increased value for the shareholders.

The repurchase program will expire at the conclusion of the company's next Annual General Meeting. As of November 6, 2012, the company has 1,437,876 Series A shares having 1 vote each and 28,141,257 Series B shares having 1/10 of a vote.